EPISODE · Sep 19, 2019 · 19 MIN
The Price of a Peanut Allergy
from What Next | Daily News and Analysis
A buzzy new drug to help treat people with a peanut allergy was recommended for approval by an FDA advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain how the cost of many prescription drugs ends up being so high.Guest: James Hamblin, staff writer at The Atlantic.Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
A buzzy new drug to help treat people with a peanut allergy was recommended for approval by an FDA advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain how the cost of many prescription drugs ends up being so high.Guest: James Hamblin, staff writer at The Atlantic.Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
The Price of a Peanut Allergy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m